This report discusses US ethical pharmaceuticals for the years 2000 and 2005, with forecasts to 2010. Topics covered include market size, distribution and commercial status, product segmentation, regulatory considerations, market environment, distribution and commercial status forecasts, product forecasts, industry composition and leading participants. Product segments cover cardiovascular agents, central nervous system agents, anti-infective agents, gastrointestinal agents, respiratory agents, and other agents. Pharmaceutical demand by distribution status (ethical and over-the-counter)
Companies Profiled
GlaxoSmithKline
Johnson & Johnson
Pfizer Incorporated
For more information, Please visit :
http://www.bharatbook.com/


